linc-ADAIN是一种人类脂肪的lincRNA,通过调节KLF5和IL-8mRNA稳定性来调节脂肪生成

Marcella E O'Reilly1, Sebastian Ho1, Johana Coronel1

  • 1Cardiometabolic Genomics Program, Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, NY, USA.

Cell reports
|May 16, 2024
PubMed
概括

长非编码RNAADIPOSE抗炎药 (linc-ADAIN) 通常限制脂肪组织的扩张. 它对肥胖的下调促进炎症和胰岛素抵抗,导致2型糖尿病和心血管疾病.